2024/12 - Final USD(K$) | %Chg (Compare to Final) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
Interest Income | 108,631,000 | 7.696% | 100,868,000 | 52,826,000 | 36,188,000 | 41,756,000 |
Interest Expense | (75,898,000) | 16.637% | (65,072,000) | (22,449,000) | (9,699,000) | (14,178,000) |
Net Interest Income | 32,733,000 | -8.557% | 35,796,000 | 30,377,000 | 26,489,000 | 27,578,000 |
Other Operating Income | 33,121,000 | 9.447% | 30,262,000 | 20,243,000 | 37,451,000 | 35,496,000 |
Total Operating Income | 65,854,000 | -0.309% | 66,058,000 | 50,620,000 | 63,940,000 | 63,074,000 |
Net Insurance Claims Incurred & Movement in Policyholders' Liabilities | 0 | -- | 0 | 0 | (14,388,000) | (12,645,000) |
Net Operating Income | 65,854,000 | -0.309% | 66,058,000 | 50,620,000 | 49,552,000 | 50,429,000 |
Operating Expenses | (33,043,000) | 3.034% | (32,070,000) | (32,701,000) | (34,620,000) | (34,432,000) |
Impairment Losses on Loans & Advances | (3,414,000) | -0.957% | (3,447,000) | (3,584,000) | 824,000 | (8,580,000) |
Other Impairment Losses | 0 | -- | 0 | 0 | 104,000 | (237,000) |
Operating Profit / (Loss) | 29,397,000 | -3.746% | 30,541,000 | 14,335,000 | 15,860,000 | 7,180,000 |
Change in FV & Impairment on Inv. Prop. | 0 | -- | 0 | 0 | 0 | 0 |
Change in FV & Impairment on Others | 0 | -- | (3,000,000) | 0 | 0 | 0 |
Profit / (Loss) on Disposal | 0 | -- | 0 | 0 | 0 | 0 |
Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 |
Share of Results of Asso. & JCEs | 2,912,000 | 3.741% | 2,807,000 | 2,723,000 | 3,046,000 | 1,597,000 |
Profit / (Loss) before Taxation | 32,309,000 | 6.462% | 30,348,000 | 17,058,000 | 18,906,000 | 8,777,000 |
Taxation | (7,310,000) | 26.274% | (5,789,000) | (809,000) | (4,213,000) | (2,678,000) |
Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- |
Non-controlling Interests | (1,020,000) | -0.585% | (1,026,000) | (690,000) | (776,000) | (870,000) |
Others | (1,062,000) | -3.542% | (1,101,000) | (1,213,000) | (1,303,000) | (1,241,000) |
Profit / (Loss) Attributable to Shareholders | 22,917,000 | 2.162% | 22,432,000 | 14,346,000 | 12,614,000 | 3,988,000 |
2024/12 - Final USD(K$) | %Chg (Compare to Final) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
Depreciation & Amortisation | 4,080,000 | 17.681% | 3,467,000 | 3,850,000 | 4,286,000 | 5,241,000 |
Directors' Emoluments | -- | -- | -- | -- | -- | -- |
2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
EPS (cts) | 125.000 | 8.696% | 115.000 | 72.000 | 62.000 | 19.000 |
DPS (cts) | 87.000 | -- | 61.000 | 32.000 | 25.000 | 15.000 |
Dividend Payout Ratio (%) | 69.600% | -- | 53.043% | 44.444% | 40.323% | 78.947% |
Cash flow per share ($) | 3.557 | -- | 2.008 | 0.975 | 5.165 | 9.035 |
NBV per share ($) | 9.244 | -- | 8.701 | 7.790 | 8.523 | 8.410 |
Remarks: | Real time quote last updated: 04/03/2025 16:34 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders (K$) | USD 22,917,000 |
%Change | 2.162% |
EPS / (LPS) | USD 1.250 |
NBV Per Share ($) | USD 9.244 |